(Q38028992)

27 August 2017

MenACWY-TT vaccine for active immunization against invasive meningococcal disease (English)

1 reference

27 August 2017

0 references

1 reference

Vassiliki Papaevangelou

series ordinal

1

1 reference

PubMed ID

22827239

27 August 2017

Nikos Spyridis

series ordinal

2

1 reference

27 August 2017

1 May 2012

1 reference

Expert Review of Vaccines

27 August 2017

1 reference

27 August 2017

11

1 reference

27 August 2017

5

1 reference

27 August 2017

523-537

1 reference

27 August 2017

Meningococcal disease

1 reference

Advances in the development of vaccines against Neisseria meningitidis

21 January 2018

1 reference

Global epidemiology of meningococcal disease.

21 January 2018

1 reference

Clinical practice. Prevention of meningococcal disease

21 January 2018

1 reference

Lessons from meningococcal carriage studies

21 January 2018

1 reference

Editorial: 100 years of epidemic meningitis in West Africa - has anything changed?

21 January 2018

1 reference

Neurodevelopmental outcome in meningococcal disease: a case-control study

21 January 2018

1 reference

Complications of meningococcal disease in college students.

21 January 2018

1 reference

Multicenter surveillance of invasive meningococcal infections in children.

21 January 2018

1 reference

Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines

21 January 2018

1 reference

The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.

21 January 2018

1 reference

Modern trends in mortality from meningococcal disease in Australia.

21 January 2018

1 reference

The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.

21 January 2018

1 reference

An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features

21 January 2018

1 reference

Social behavior and meningococcal carriage in British teenagers

21 January 2018

1 reference

Prospects for vaccine prevention of meningococcal infection

21 January 2018

1 reference

Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis.

21 January 2018

1 reference

Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage

21 January 2018

1 reference

Prevention of meningococcal serogroup C disease by NeisVac-C.

21 January 2018

1 reference

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation

21 January 2018

1 reference

Meningococcal disease in South Africa, 1999-2002.

21 January 2018

1 reference

From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease

21 January 2018

1 reference

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

21 January 2018

1 reference

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

21 January 2018

1 reference

Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).

21 January 2018

1 reference

Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis in Latin America and the Caribbean: SIREVA II, 2000-2005

21 January 2018

1 reference

Meningococcal carriage by age: a systematic review and meta-analysis

21 January 2018

1 reference

Carriage of meningococci by university students, United Kingdom.

21 January 2018

1 reference

Meningococcal carriage in the African meningitis belt

21 January 2018

1 reference

Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.

21 January 2018

1 reference

Epidemiological profile of meningococcal disease in the United States

21 January 2018

1 reference

Host genetic determinants of Neisseria meningitidis infections.

21 January 2018

1 reference

Risk factors for meningococcal disease in college students

21 January 2018

1 reference

Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study

21 January 2018

1 reference

Meningococcal C conjugate vaccine: the experience in England and Wales

21 January 2018

1 reference

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

21 January 2018

1 reference

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

21 January 2018

1 reference

Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.

21 January 2018

1 reference

Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

21 January 2018

1 reference

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization

21 January 2018

1 reference

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

21 January 2018

1 reference

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

21 January 2018

1 reference

Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

21 January 2018

1 reference

Meningococcal surrogates of protection--serum bactericidal antibody activity

21 January 2018

1 reference

Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy

21 January 2018

1 reference

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

21 January 2018

1 reference

Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial

21 January 2018

1 reference

Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile

21 January 2018

1 reference

Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults

21 January 2018

1 reference

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents

21 January 2018

1 reference

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants

21 January 2018

1 reference

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.

21 January 2018

1 reference

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

21 January 2018

1 reference

Genetic Analysis of Meningococci Carried by Children and Young Adults

21 January 2018

1 reference

The natural history of meningococcal carriage and disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.32

1 reference

27 August 2017

1 reference

PubMed ID

22827239